Elan Corporation, plc (ELN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: William Partmann who started this subject	11/9/2001 10:40:47 AM
From: William Partmann	of 10345

YESSSSSSSSSSSSSS..Elan says FDA approves migraine treatment NEW YORK, Nov 9 (Reuters) - Irish drug maker Elan Corp Plc (NYSE:ELN - news) said on Friday U.S. regulators approved its migraine drug, called Frova. Elan and industry watchers alike had greatly anticipated the approval of the drug. Analysts are forecasting the treatment will achieve peak sales of $213.7 million (150 million pounds) a year. ``The FDA's approval of Frova is a key milestone in advancing our pipeline of important products for patients with neurological disorders,'' Donal Geaney, chairman and chief executive of Elan, said in a statement. Elan said 10 percent of the U.S. population suffer from migraine attacks, or about 27 million people.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next